09.02.2013 Views

Cancer Research in Switzerland - Krebsliga Schweiz

Cancer Research in Switzerland - Krebsliga Schweiz

Cancer Research in Switzerland - Krebsliga Schweiz

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

eport long-term impairment of sense of well-be<strong>in</strong>g, reflected<br />

by low levels of health-related quality of life<br />

(HRQoL) and high levels of depression and anxiety. Very<br />

little effort has been expended <strong>in</strong> exam<strong>in</strong><strong>in</strong>g whether<br />

behavioural <strong>in</strong>terventions can serve to improve dist<strong>in</strong>ct<br />

parameters of well-be<strong>in</strong>g, e. g. HRQoL, depression, fatigue<br />

and anxiety.<br />

Aim<br />

M<strong>in</strong>dfulness-based <strong>in</strong>tervention (MBI) is a group behavioural<br />

program aimed at improv<strong>in</strong>g aspects of well-be<strong>in</strong>g<br />

for patients with a broad spectrum of chronic disorders<br />

(detailed description provided later). The primary goal of<br />

this <strong>in</strong>vestigation is to exam<strong>in</strong>e whether MBI is a feasible<br />

and effective <strong>in</strong>tervention for HSCT survivors <strong>in</strong> terms of<br />

enhanc<strong>in</strong>g different dimensions of HRQoL (e. g. psychological<br />

function<strong>in</strong>g, positive emotions, social contact and<br />

ability to enjoy life) and decreas<strong>in</strong>g depression, fatigue<br />

and anxiety.<br />

Methods<br />

Us<strong>in</strong>g a controlled patient-preference procedure, MBI is<br />

compared to a comparison <strong>in</strong>tervention of augmented optimal<br />

medical care, where patients, additional to usual<br />

medical care, receive brief telephone medical and psychosocial<br />

consultations twice a month dur<strong>in</strong>g the <strong>in</strong>tervention<br />

phase. Feasibility of <strong>in</strong>terventions will be evaluated by<br />

measur<strong>in</strong>g aspects of acceptability of <strong>in</strong>terventions (percentage<br />

of <strong>in</strong>vited patients who participate, the dropout<br />

rate for the program, the average weekly attendance rate<br />

and the degree to which patients perceive that their personal<br />

goals for the <strong>in</strong>tervention have been met). Efficacy<br />

of treatment will be evaluated by validated <strong>in</strong>ventories of<br />

HRQoL, depression and fatigue as primary outcomes.<br />

Anxiety, personal growth and physical health status will<br />

be employed as secondary measures. We plan to <strong>in</strong>clude<br />

100 patients <strong>in</strong> the study and to exam<strong>in</strong>e benefits directly<br />

after the <strong>in</strong>tervention period and at 3 months follow-up.<br />

Results<br />

This study is ongo<strong>in</strong>g, and 51 patients are thus far participat<strong>in</strong>g.<br />

Few patients dropped out of the study before<br />

complet<strong>in</strong>g the <strong>in</strong>tervention (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!